Skip to main content
. 2024 Aug 28;8(6):923–934. doi: 10.1007/s41669-024-00520-8

Table 1.

Base-case probabilistic analysis results, OCS-only daily dose of 10 mg, hypothetical 50% dose sparing from the OCS-sparing regimen scenario

Outcome Intervention arm (95% CI) OCS-only arm (95% CI) Incremental (95% CI)
Costs £26,566 (£24,284–£29,342) £28,969 (£26,477–£32,010) −£2403 (−£2203 to −£2668)
QALYs 10.197 (8.761–11.389) 10.126 (8.761–11.389) 0.071 (0.064–0.077)
Life years 24.975 (24.401–25.544) 24.769 (24.201–25.329) 0.205 (0.197–0.213)

CI confidence interval, OCS oral corticosteroids, QALYs quality-adjusted life-years